United States · FDA National Drug Code directory
Levothyroxine Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70511-112_9efa2867-7721-478a-a1c3-e34eeb3a1937
- Product NDC
- 70511-112
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- LEVOTHYROXINE SODIUM ANHYDROUS
- Labeler
- MAIA Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20181227
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVOTHYROXINE SODIUM ANHYDROUS — 200 ug/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-USE in 1 CARTON (70511-112-10) / 5 mL in 1 VIAL, SINGLE-USE · 70511-112-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →